According to the previous studies, the data have shown that the CD28/CTLA-4-CD80/CD86 pathway plays an important role in accelerating the development of atherosclerotic lesions, and was considered as an important potential target in immune regulation of atherosclerosis. This evidence concerns the gene CD86 and atherosclerosis.